This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Motoko Oshida: Innovator in Enzyme-Driven Chemical Production
Introduction
Motoko Oshida is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of chemical production, particularly through her innovative methods involving enzymes. Her work has the potential to impact various applications in pharmaceuticals and biotechnology.
Latest Patents
Motoko Oshida holds a patent for a method of producing bicyclo[3.1.0] hexane derivative using enzymes. This production method allows for the creation of a bicyclo[3.1.0]hexane derivative, which is useful as a metabotropic glutamate receptor modulator. The process involves converting a compound represented by Formula (II) into a compound represented by Formula (III) through a reaction with an acyl group donor in the presence of a microorganism-derived enzyme. This method is advantageous as it does not require an expensive optically active trans hydroxy ester as a starting material, nor does it involve a fluorination reaction that necessitates ultralow temperature conditions. Additionally, the asymmetric synthesis can be performed closer to the final product, making it a viable option for mass production.
Career Highlights
Motoko Oshida is associated with Taisho Pharmaceutical Co., Ltd., where she continues to advance her research and development efforts. Her innovative approach to enzyme-driven synthesis has garnered attention in the scientific community, highlighting her role as a leader in her field.
Collaborations
Motoko has collaborated with notable colleagues, including Mitsuaki Hirotsuka and Joji Sasaki. These partnerships have further enriched her research and contributed to the advancement of their shared goals in chemical innovation.
Conclusion
Motoko Oshida's contributions to enzyme-driven chemical production exemplify the intersection of innovation and practical application in the pharmaceutical industry. Her work not only enhances the efficiency of chemical synthesis but also opens new avenues for research and development.